Health Care News and Research

RSS

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.

23 Oct 2018

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

MWH Medical Pte Ltd, a leading homegrown medical group, and Siemens Healthineers are pleased to announce the launch of the first Asia Reference Center through their partnership.

From Siemens Healthineers 23 Oct 2018

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.

23 Oct 2018

Gavin Newsom is bullish on single-payer — except when he’s not

Twenty minutes before the only scheduled 2018 California's gubernatorial debate, Lt. Gov. Gavin Newsom rolled into the San Francisco parking garage in a black SUV. Through the tinted windows, a soft overhead light slightly illuminated the front-runner's chiseled features and slicked-back hair.

23 Oct 2018

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.

23 Oct 2018

Marketplace subsidies may be option in 2020 for plans without blanket benefits

States would be able to use federal funding to provide subsidies to people buying short-term health insurance policies, which typically don't provide comprehensive coverage, under guidance released Monday by the Trump administration.

23 Oct 2018

Researchers identify common genetic connection in lung conditions

An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.

22 Oct 2018

Stress related to social stigma negatively impacts mental health of autistic people

Stress related to social stigma may be the reason why autistic people experience more mental health problems than the general population, dispelling past theories that the condition itself is the origin of such distress.

22 Oct 2018

Politicians hop aboard ‘Medicare-for-all’ train, destination unknown

After decades in the political wilderness, "Medicare-for-all" and single-payer health care are suddenly popular. The words appear in political advertisements and are cheered at campaign rallies — even in deep-red states.

22 Oct 2018

Primary care doctors ‘not doing enough’ to curb STDs

Julie Lopez, 21, has been tested regularly for sexually transmitted diseases since she was a teenager. But when Lopez first asked her primary care doctor about screening, he reacted with surprise, she said.

22 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.

22 Oct 2018

Free phone app helps low-income obese patients to lose weight

With the help of a free phone app, low-income obese patients with signs of cardiovascular risk lost a clinically meaningful amount of weight, finds new research from Duke University.

22 Oct 2018

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).

22 Oct 2018

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.

22 Oct 2018

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.

22 Oct 2018

Advancement in medical imaging methods for health care

The fast-moving advancement in medical imaging technology has revolutionized health care science. When information technology is integrated with imaging technology, it takes health care to new horizons. On the other hand, there is an increase in the number of health care workers to meet the need of growing population and requirement of quality health services.

22 Oct 2018

IU researchers receive $1.55 million from NIH to improve chronic-disease management

The National Institutes of Health, under the National Library of Medicine's program on data science research, has awarded $1.55 million to an interdisciplinary team lead by Luis Rocha, a professor of informatics and the director of the NSF-NRT complex networks and systems program at the Indiana University School of Informatics, Computing and Engineering.

20 Oct 2018

Health Care News and Research

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Gavin Newsom is bullish on single-payer — except when he’s not

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

Marketplace subsidies may be option in 2020 for plans without blanket benefits

Researchers identify common genetic connection in lung conditions

Stress related to social stigma negatively impacts mental health of autistic people

Politicians hop aboard ‘Medicare-for-all’ train, destination unknown

Primary care doctors ‘not doing enough’ to curb STDs

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Free phone app helps low-income obese patients to lose weight

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Advancement in medical imaging methods for health care

IU researchers receive $1.55 million from NIH to improve chronic-disease management

Event guide: 3rd Measuring Patient Engagement Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News